GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSL:MEDI) » Definitions » Cyclically Adjusted Revenue per Share

Medistim ASA (OSL:MEDI) Cyclically Adjusted Revenue per Share : kr22.87 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medistim ASA's adjusted revenue per share for the three months ended in Mar. 2024 was kr7.305. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr22.87 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Medistim ASA's average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 13.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medistim ASA was 13.00% per year. The lowest was 7.90% per year. And the median was 10.70% per year.

As of today (2024-06-10), Medistim ASA's current stock price is kr180.50. Medistim ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr22.87. Medistim ASA's Cyclically Adjusted PS Ratio of today is 7.89.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medistim ASA was 23.03. The lowest was 4.75. And the median was 12.07.


Medistim ASA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Medistim ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Cyclically Adjusted Revenue per Share Chart

Medistim ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.40 15.53 17.58 19.99 22.39

Medistim ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.63 21.47 21.72 22.39 22.87

Competitive Comparison of Medistim ASA's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Medistim ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Cyclically Adjusted PS Ratio falls into.



Medistim ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medistim ASA's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.305/132.6000*132.6000
=7.305

Current CPI (Mar. 2024) = 132.6000.

Medistim ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.644 97.500 3.596
201409 2.873 98.500 3.868
201412 3.620 98.600 4.868
201503 3.198 99.200 4.275
201506 3.160 100.100 4.186
201509 3.403 100.600 4.485
201512 4.035 100.900 5.303
201603 3.609 102.500 4.669
201606 3.709 103.800 4.738
201609 3.743 104.200 4.763
201612 3.419 104.400 4.343
201703 4.094 105.000 5.170
201706 3.809 105.800 4.774
201709 4.168 105.900 5.219
201712 4.230 106.100 5.287
201803 4.079 107.300 5.041
201806 4.193 108.500 5.124
201809 4.269 109.500 5.170
201812 5.187 109.800 6.264
201903 4.878 110.400 5.859
201906 5.157 110.600 6.183
201909 4.702 111.100 5.612
201912 4.885 111.300 5.820
202003 5.665 111.200 6.755
202006 4.535 112.100 5.364
202009 4.571 112.900 5.369
202012 4.785 112.900 5.620
202103 5.625 114.600 6.509
202106 6.016 115.300 6.919
202109 5.598 117.500 6.317
202112 5.657 118.900 6.309
202203 6.357 119.800 7.036
202206 6.430 122.600 6.954
202209 6.372 125.600 6.727
202212 7.447 125.900 7.843
202303 7.068 127.600 7.345
202306 7.512 130.400 7.639
202309 6.786 129.800 6.932
202312 7.115 131.900 7.153
202403 7.305 132.600 7.305

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Medistim ASA  (OSL:MEDI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medistim ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=180.50/22.87
=7.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medistim ASA was 23.03. The lowest was 4.75. And the median was 12.07.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medistim ASA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Medistim ASA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA (OSL:MEDI) Business Description

Industry
Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSL:MEDI) Headlines